Immatics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immatics and other ETFs, options, and stocks.About IMTX
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics.
IMTX Key Statistics
Stock Snapshot
The current Immatics(IMTX) stock price is $7.08, with a market capitalization of 1.06B. The stock trades at a price-to-earnings (P/E) ratio of -3.78.
On 2026-10-15, Immatics(IMTX) stock moved within a range of $6.64 to $7.20. With shares now at $7.08, the stock is trading +6.6% above its intraday low and -1.7% below the session's peak.
Trading volume for Immatics(IMTX) stock has reached 758.59K, versus its average volume of 957.32K.
The stock's 52-week range extends from a low of $6.64 to a high of $12.41.
The stock's 52-week range extends from a low of $6.64 to a high of $12.41.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.